Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan D Sniderman

Showing results (81-90 of 164) with videos related to

Pageof 17
Sort By:
Current Opinion in Lipidology|October 24, 2014
Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoBAllan D Sniderman, Benoit Lamarche, John H Contois, et al.
International Journal of Epidemiology|May 19, 2007
Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesisAllan D Sniderman, Raj Bhopal, Dorairaj Prabhakaran, et al.
Nephrology (Carlton, Vic.)|October 9, 2016
Serial versus single troponin measurements for the prediction of cardiovascular events and mortality in stable chronic haemodialysis patientsThomas A Mavrakanas, Allan D Sniderman, Paul E Barré, et al.
BMC Nephrology|November 12, 2013
Elevated troponin I levels but not low grade chronic inflammation is associated with cardiac-specific mortality in stable hemodialysis patientsAhsan Alam, Andrea Palumbo, Istvan Mucsi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 11, 2020
The clinical utility of apoB versus LDL-C/non-HDL-CCiaran N Kohli-Lynch, George Thanassoulis, Andrew E Moran, et al.
Circulation|October 20, 2004
Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis StudyNaveed Sattar, Ken Williams, Allan D Sniderman, et al.
Clinical Biochemistry|October 19, 2006
Differential impact of plasma triglycerides on HDL-cholesterol and HDL-apo A-I in a large cohortAndré J Tremblay, Allan D Sniderman, Claude Gagné, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Cardiovascular death in dialysis patients: lessons we can learn from AURORAAllan D Sniderman, Amirreza Solhpour, Ahsan Alam, et al.
Clinical Science (London, England : 1979)|September 18, 2007
Non-HDL cholesterol and apoB in dyslipidaemiaAllan D Sniderman, Jean-Charles Hogue, Jean Bergeron, et al.
Mayo Clinic Proceedings|October 2, 2013
The necessity for clinical reasoning in the era of evidence-based medicineAllan D Sniderman, Kevin J LaChapelle, Nikodem A Rachon, et al.
Pageof 17

Showing results (81-90 of 164) with videos related to

Sort By:
Pageof 17
Current Opinion in Lipidology|October 24, 2014
Discordance analysis and the Gordian Knot of LDL and non-HDL cholesterol versus apoBAllan D Sniderman, Benoit Lamarche, John H Contois, et al.
International Journal of Epidemiology|May 19, 2007
Why might South Asians be so susceptible to central obesity and its atherogenic consequences? The adipose tissue overflow hypothesisAllan D Sniderman, Raj Bhopal, Dorairaj Prabhakaran, et al.
Nephrology (Carlton, Vic.)|October 9, 2016
Serial versus single troponin measurements for the prediction of cardiovascular events and mortality in stable chronic haemodialysis patientsThomas A Mavrakanas, Allan D Sniderman, Paul E Barré, et al.
BMC Nephrology|November 12, 2013
Elevated troponin I levels but not low grade chronic inflammation is associated with cardiac-specific mortality in stable hemodialysis patientsAhsan Alam, Andrea Palumbo, Istvan Mucsi, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 11, 2020
The clinical utility of apoB versus LDL-C/non-HDL-CCiaran N Kohli-Lynch, George Thanassoulis, Andrew E Moran, et al.
Circulation|October 20, 2004
Comparison of the associations of apolipoprotein B and non-high-density lipoprotein cholesterol with other cardiovascular risk factors in patients with the metabolic syndrome in the Insulin Resistance Atherosclerosis StudyNaveed Sattar, Ken Williams, Allan D Sniderman, et al.
Clinical Biochemistry|October 19, 2006
Differential impact of plasma triglycerides on HDL-cholesterol and HDL-apo A-I in a large cohortAndré J Tremblay, Allan D Sniderman, Claude Gagné, et al.
Clinical Journal of the American Society of Nephrology : CJASN|January 9, 2010
Cardiovascular death in dialysis patients: lessons we can learn from AURORAAllan D Sniderman, Amirreza Solhpour, Ahsan Alam, et al.
Clinical Science (London, England : 1979)|September 18, 2007
Non-HDL cholesterol and apoB in dyslipidaemiaAllan D Sniderman, Jean-Charles Hogue, Jean Bergeron, et al.
Mayo Clinic Proceedings|October 2, 2013
The necessity for clinical reasoning in the era of evidence-based medicineAllan D Sniderman, Kevin J LaChapelle, Nikodem A Rachon, et al.
Pageof 17